In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug

  1. Gonzalez-Alvarez, I.
  2. Ruiz-Picazo, A.
  3. Selles-Talavera, R.
  4. Figueroa-Campos, A.
  5. Merino, V.
  6. Bermejo, M.
  7. Gonzalez-Alvarez, M.
Journal:
Pharmaceutics

ISSN: 1999-4923

Year of publication: 2024

Volume: 16

Issue: 3

Type: Article

DOI: 10.3390/PHARMACEUTICS16030390 GOOGLE SCHOLAR lock_openOpen access editor HANDLE: https://hdl.handle.net/10550/107102
RODERIC. Repositorio Institucional de la Universitat de Valéncia: lock_openOpen access Handle

Sustainable development goals

Data source: Scopus